Jayesh Desai

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

Jayesh Desai
May 30, 2025, 13:16 | Insight
Triple Therapy Regimen Significantly Improves Survival in BRAF V600E-Mutated Metastatic Colorectal Cancer
Approximately 8 to 12% of patients with colorectal cancer have BRAF mutations Treatment with the…
Feb 3, 2025, 14:01 | Blog
Vivek Subbiah: The Role of Consortia in the Delivery of Precision Oncology Early Phase Clinical Trials
Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute, posted on…
Jan 20, 2025, 14:17 | Science
Hung Trinh: Bispecific Antibodies in Cancer Therapy
Hung Trinh, CMC/MFG Consultant and Managing Director at Vertex Biopharm Consulting, shared a post on…
Dec 16, 2024, 11:37 | Science
FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma
On December 13, 2024, the FDA approved cosibelimab-ipdl, a PD-L1 blocking antibody, for adults with…
Oct 27, 2024, 12:01 | Blog
Norbert Kraut: Exciting progress on targeting KRAS at ENA Symposium 2024
Norbert Kraut, Global Head of Cancer Research, Boehringer Ingelheim, shared on X: "Exciting progress on…
Sep 26, 2024, 08:20 | Blog
Anirban Maitra: Molecular profiling of BRAF-V600E-mutant metastatic colorectal cancer in the phase 3 BEACON CRC trial
Anirban Maitra shared on X: "New study in Nature Medicine from Scott Kopetz and colleagues.…
Sep 2, 2024, 08:43 | Insight
Lewis Au: Preclinical and clinical developments of Bispecific Antibodies
Lewis Au, GU and GI Medical Oncologist at Peter Mac Cancer Centre, shared a post…
All: 7 Posts: 1 - 100
Special Coverage